Le Lézard

FDA Approves Expanded Indication for Max 3tm Syringeless MR Injector from Bracco

Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a global leader in diagnostic imaging, announced today that the U.S. Food and Drug Administration (FDA) has expanded the ...